Indian Pharma industry moving towards formulations

Indian Pharma industry is slowing moving up the value chain. Earlier it used to manufacture active pharmaceutical ingredient at low cost compared to world. Now with competition from China, which provides API at 15-20% low cost, it makes sense to shift focus elsewhere. Many top companies like Lupin, Novartis, Ranbaxy have less revenue stream from API than from formulations. There could also be the reason that formulation business has grown faster than APIs for some companies. API is low scale commodity with low margin. Moreover, with a large number of patent expiries in developed markets like the US and Europe, Indian companies, with skills to develop and manufacture low-cost generic drugs, see a much more lucrative opportunity there than utilising their capacities for manufacturing APIs.
Read More

  • No Image
    Nagpur Pyrolusite Pvt Ltd

    Nagpur Pyrolusite Pvt. Ltd is engaged in Manufacturing, Exporting, Marketing and Distribution of Manganese Dioxide, Granulated Manganese Dioxide used especially for water purifi

  • No Image
    Natco Pharma Ltd

    Head quartered in Hyderabad, India, Natco has five formulation locations, across India ? two in Dehradun (Uttarakhand), one in Kothur (Mahboobnagar, Telangana), One in Nagarjuna

  • No Image
    Natural Capsules Ltd

    Natural Capsules Ltd established in the year 1993 at Bangalore It has a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsu

  • No Image
    Natural Remedies Pvt Ltd

    Natural Remedies Private Limited, headquartered at Bangalore, Karnataka is a manufacturer of standardized herbal extracts, phyto-chemicals and herbal veterinary healthcare produ